Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Newsstand

Tylor Megill, Reed Garrett Recommended For Tommy John Surgery

By | at

Two Mets pitchers are facing significant long-term injuries, as The Athletic’s Tim Britton reports that Tommy John surgery has been recommended for both Tylor Megill and Reed Garrett.  Both right-handers are considering their options before committing to the TJ procedure, plus Garrett already has another surgery awaiting in the form of a planned procedure to move a nerve in his right arm.

The 30-year-old Megill last pitched on June 14, as he was sidelined by an elbow sprain that (according to the pitcher) didn’t come with any structural damage at the time.  However, Megill’s rehab assignment was shut down due to some renewed elbow discomfort during a Triple-A start on September 7, and the latest set of tests has apparently delivered the unwelcome news of UCL damage.

Garrett has been battling elbow issues for over a month, as he missed two weeks (spanning the end of August and start of September) due to elbow inflammation.  That minimal IL stint didn’t seem like cause for concern until yesterday, when Garrett was returned to the 15-day IL with a sprain in his throwing elbow.

Britton writes that Garrett could opt for a PRP injection and then see if that is enough to heal his elbow, yet the nerve surgery and the attached four-month recovery period are additional obstacles.  If Garrett got a Tommy John surgery relatively soon, he would very likely be ready to go by Opening Day 2027.  If he goes the PRP route, he wouldn’t be able to get the shot until after he is fully recovered from the nerve procedure, so there’s a risk that Garrett would end up wasting a lot of recovery time if he ended up needing a TJ surgery anyway.  Garrett turns 33 in January, adding to the ticking-clock nature of what an extended absence means for his career as a whole.

At the very least, the 2025 season at a minimum is over for both pitchers.  That already somewhat seemed like the case anyway given Megill’s setback after a lengthy absence and Garrett’s late-season elbow sprain, yet now even the faint hope of a return in the event of a deep Mets playoff run has been squashed.  It leaves the pitching-needy Mets with even more questions to address about their arms depth if New York even makes it into the postseason, but the bigger-picture issue is clearly the unfortunate possibility that Megill and Garrett will both miss the entire 2026 campaign.

Megill has primarily pitched as a starter over his five MLB seasons (all with the Mets), but he has been deployed more as a back-end rotation arm or even a fill-in rather than a truly stable member of the rotation.  Megill has generally done well when given the opportunity, and he took a step forward in 2025 by posting a 3.95 ERA over 14 starts and 68 1/3 innings.  His 10.8% walk rate is on the high side, but Megill’s 29.2% strikeout rate was a career best, and he also had very strong whiff and barrel rates.

2025 is also Garrett’s fifth Major League season, though he also spent the 2020-21 seasons pitching in Japan.  Garrett joined the Mets on a waiver claim from the Orioles in 2023, and then finally carved out a foothold for himself in the majors as a workhorse member of New York’s bullpen.  Since Opening Day 2024, Garrett has a 3.83 ERA in 111 appearances and 112 2/3 innings for the Amazins, with a 30.3% strikeout rate and 11.5% walk rate.  Apart from the control issues, Garrett has been a pretty stable member of a Mets bullpen that has seemed to be in constant flux.

Megill is in his first year of arbitration eligibility, and is playing on a $1.975MM salary in 2025.  Garrett is only arb-eligible for the first time this coming offseason, and as a non-closing relief pitcher, would have been in line for a pretty modest guaranteed salary in 2026.  Between these low salaries and the good numbers the duo have posted in their time in Queens, the Mets will probably still tender both pitchers contracts even in the event that they undergo TJ surgeries, since the team will still have control when both are (presumably) healthy in 2027.

Astros Place Yordan Alvarez On Injured List

By | at

The Astros have placed outfielder/designated hitter Yordan Alvarez on the 10-day injured list with a left ankle sprain, per Chandler Rome of The Athletic, retroactive to September 16th. That open an active roster spot for infielder Isaac Paredes. It was reported earlier that Paredes would be reinstated from the 60-day IL. To open a 40-man spot for Paredes, reliever Kaleb Ort has been transferred to the 60-day IL.

Earlier this week, Alvarez slipped on home plate while coming around to score a run against the Rangers, as seen in this video from MLB.com. After the game, manager Joe Espada said Alvarez would be going for an MRI and Alvarez was seen in a walking boot and on crutches. The next day, Espada described the injury as “pretty significant” and that Alvarez would be “out for a while.”

The Astros didn’t initially place Alvarez on the IL as they waited to evaluate his progress, but now have decided to do so. IL placements can be backdated by three days, so Alvarez can be reinstated in a week.

It’s unclear if the injury will actually allow that to be a real possibility, however, making it a situation to watch going forward. Alvarez has been one of the best hitters alive in recent years. He slumped earlier this year but it was later revealed he had an undiagnosed finger fracture. He spent some time on the IL healing up and seemed to be back to his old self once he returned. He slashed .369/.462/.569 in 78 plate appearances between that previous IL stint and this new one.

Losing that kind of bat is obviously less than ideal for the Astros, especially when they are still playing meaningful games. They are tied with the Mariners for the West division lead and the two clubs begin an incredibly important series against each other tonight. If the Astros lose that series and fall back of the M’s, they would still be in possession of a Wild Card spot, but that would put them at risk of missing the playoffs completely. The Guardians are the top team outside the postseason spots right now and they are only 2.5 games back of Houston.

Even if the Astros hang on and make it to October, they will be hamstrung unless Alvarez can make it back. In the event he can return to the club for the final days of the regular season or in the postseason, it could create a bit of a lineup clog. Paredes is coming back after a lengthy injury absence of his own due to a hamstring strain. He has been taking batting practice lately but hasn’t played any rehab games. He’s serving as the designated hitter tonight but it’s unclear if the Astros have any intention of having him play the field in the coming weeks.

Getting Alvarez back to a state of semi-health where he can hit would be great, though it’s less than perfect if both he and Paredes are in that bucket. That would mean one of them would have to sit or be forced into the field each day. Jose Altuve is also ideally suited for a DH role these days since his glovework isn’t great anywhere, but he’ll have to be out there in the field somewhere if Paredes or Alvarez are in the DH spot going forward.

As for Ort, this transfer definitively ends his season. He landed on the 15-day IL in early September due to right elbow inflammation. It was reported shortly thereafter that he wasn’t likely to return during the regular season. This transfer also wipes out any chance of him appearing in the postseason, even if the Astros make a deep run. He finishes the year with a 4.89 earned run average in 46 innings. He can be retained for four more years after this one but is out of options and may be on the roster bubble this winter, given his mediocre results this year and uncertain health status.

Photo courtesy of Erik Williams, Imagn Images

Astros To Activate Isaac Paredes

By | at

The Astros expect to reinstate infielder Isaac Paredes from the injured list prior to tonight’s pivotal series opener against the Mariners, reports Brian McTaggart of MLB.com. The 26-year-old slugger has been out since July 19 due to a significant hamstring strain. He’s on the 60-day injured list, so the ’Stros will need to open a spot on the 40-man roster to make Paredes’ return official.

Paredes, 26, came to Houston as part of the offseason Kyle Tucker blockbuster with the Cubs. His pull-heavy, flyball approach has proven a perfect match with Houston’s Daikin Park. Through his first 94 games and 409 plate appearances as an Astro, the righty-swinging Paredes has slashed .259/.359/.470 with 19 homers. However, while Paredes has performed better at home, it’d be unfair to use his strong season to suggest he’s simply a product of the short left-field porch in Houston. Ten of those 19 round-trippers have come at home, where he’s slashed .253/.360/.483, but Paredes has been nearly as good on the road, hitting .266/.359/.457.

There’s some risk in the accelerated return to the lineup. General manager Dana Brown earlier this week said there was only an “outside chance” that Paredes could return this weekend. He’s taken live batting practice but hasn’t played in a single minor league rehab game. However, Yordan Alvarez recently suffered a significant ankle sprain that’s kept him out of the lineup since Sept. 15 and seems to have relegated him to a bench/pinch-hitting role for the time being. Houston hasn’t placed Alvarez on the injured list, but manager Joe Espada said earlier this week that he’ll be “out for a while” after an MRI revealed the sprain.

Given that ill-timed Alvarez injury, it seems the Astros are rolling the dice on another of their best bats being healthy enough to contribute in a series that could determine the outcome of the AL West. The Astros and Mariners are tied with identical 84-69 records heading into this three-game set in Houston. The deadline reacquisition of Carlos Correa — paired with that Alvarez injury — seems to suggest that Paredes will be a DH option for the time being. Scorching-hot Jeremy Pena will hold things down at shortstop, while Correa will handle a hot corner that had previously been manned by Paredes.

While Paredes does have some limited experience at second base, it’s hard to imagine Houston throwing him into a position he hasn’t played all season at a time when his hamstring likely isn’t 100% healthy. And with Christian Walker entrenched at first base, there aren’t many other options for Paredes beyond designated hitter. That’s probably for the best anyhow, given his murky health status. Paredes and the Astros will square off against a formidable trio of Seattle righties this weekend, taking on Bryan Woo, George Kirby and Logan Gilbert (in that order).

Clayton Kershaw To Retire After 2025 Season

By | at

Left-hander Clayton Kershaw is going to retire as a player after the current campaign, per an announcement from the Dodgers. His final regular season start at Dodger Stadium will be on Friday.

“On behalf of the Dodgers, I congratulate Clayton on a fabulous career and thank him for the many moments he gave to Dodger fans and baseball fans everywhere, as well as for all of his profound charitable endeavors,” said Mark Walter, owner and chairman of the Dodgers, in a club press release. “His is a truly legendary career, one that we know will lead to his induction in the Baseball Hall of Fame.”

In the next few weeks, Kershaw will be wrapping up a surefire Hall-of-Fame career. He will have spent the entirety of that span with one club, an increasingly rare phenomenon in today’s game. The Dodgers selected him with the seventh overall pick back in 2006 and he’s never been a part of any other franchise.

Kershaw was up in the majors by 2008 and he had a solid enough debut season. He tossed 107 2/3 innings for the Dodgers that year, allowing 4.26 earned runs per nine. He took a big step forward the following year, with a 2.79 ERA in 171 frames. There was another step forward in terms of workload in 2010, as he got up to 204 1/3 innings, with a 2.91 ERA.

From there, he kicked off the strongest stretch of his career and one of the best of any pitcher in the modern era. From 2011 to 2015, he tossed at least 227 innings in four of those five campaigns. The lone exception was 2014, where a shoulder strain limited him to 198 1/3 innings. For that five-year span, he tossed 1,128 innings with a 2.11 ERA, 28.6% strikeout rate, 5.6% walk rate and 47.4% ground ball rate. FanGraphs credited with 37.1 wins above replacement for that span, more than seven wins per season. That was easily the most in the majors for that stretch. Félix Hernández was second with 26.2 fWAR.

From there, injuries limited Kershaw’s production in terms of quantity, but the quality was still there. He never again hit 180 innings in a season, with back problems being a recurring theme, but still kept his ERA in the 2.00 to 3.00 range most of the time. Though it was a step down from his peak, he tossed 140-180 frames in each season from 2016 to 2019, never finishing with an ERA higher than 3.03. He made ten starts with a 2.16 ERA in the shortened 2020 season.

Kershaw’s run as one of the best pitchers alive, often the very best, coincided with a golden age for the franchise. It’s hard to believe now, as the Dodgers have been so consistently good lately, but they were spinning their wheels for a while in the earlier parts of this millenium. They didn’t make the playoff in the 1997 to 2003 seasons, mostly hovering around .500. Things improved a bit from there but still weren’t amazing. They made the playoffs in 2004, 2006, 2008 and 2009, but then missed in three straight years from 2010 to 2012.

But they made the playoffs in 2013 and have continued to do so in every season since then. Assuming they eventually clinch a spot here in 2025, it will be 13 seasons in a row. There was a lot of playoff heartbreak in there but the Dodgers did win it all in 2020 and again in 2024.

More recently, Kershaw’s injury absences have become more pronounced as he has pushed into his late-30s. He was limited to 120-130 innings in the 2021 to 2023 campaigns, though still with good results on a rate basis. He only made seven starts last year, initially held back by offseason shoulder surgery before later having his season finished by dual surgeries on his toe and knee to repair a ruptured plantar plate and a torn meniscus.

He’s been able to get back to health here in 2025 and go out on a decent note. His strikeout rate is way down to 17% but he has managed to post a 3.53 ERA in 102 innings. As mentioned, he’ll be making another start tomorrow and could perhaps take the ball once more as the Dodgers finish the season with a six-game road trip.

Kershaw became a free agent a few times and occasionally seemed to flirt with the idea of signing with his hometown Rangers, but he always ended up back with the Dodgers. His first significant payday was back in 2014, when he and the Dodgers agreed to a seven-year, $215MM extension. That’s still the largest guarantee given to a pitcher on an extension. Only six free agent deals for pitchers (Shohei Ohtani, Yoshinobu Yamamoto, Gerrit Cole, Stephen Strasburg, Max Fried, David Price) have surpassed that guarantee.

That deal allowed Kershaw to opt out after 2018, which he did, but he and the Dodgers agreed to a new pact. A three-year, $91MM deal covering the 2019 to 2021 seasons kept him in Los Angeles and was the first time a pitcher hit the $30MM mark in terms of average annual value. His subsequent deals were more modest one- or two-year pacts as he seemed to go year-to-year with deciding whether or not he wanted to keep going.

Kershaw’s career numbers aren’t final yet because he still has at least one more game to go. As of today, he has 2,844 2/3 innings under this belt with a 2.54 ERA, 27.1% strikeout rate, 6.3% walk rate and 46.7% ground ball rate. He has tallied 222 wins and 96 losses, 25 complete games, 15 shutouts and 3,039 total punchouts. FanGraphs credits him with 78.7 WAR with Baseball Reference at 80.4. He also tossed 194 1/3 postseasons innings, though with a 4.49 ERA.

He made 11 All-Star teams and won three Cy Young awards. He was the National League Most Valuable Player in 2014, a rare feat for a pitcher. He also tossed a no-hitter that year. He won the World Series in 2020 and 2024, though he was on the injured list during the second of those titles. MLBTR salutes Kershaw on an excellent career and wishes him the best for his post-playing days.

Photos courtesy of Wendell Cruz, Neville E. Guard, Imagn Images

Lucas Giolito Converts Club Option To Mutual Provision

By | at

Lucas Giolito completed four innings against the Athletics tonight. That pushes him beyond 140 frames on the season, clinching a contractual milestone that’ll have an impact on the upcoming free agent class. Giolito has hit the vesting threshold needed to convert the Red Sox’s $14MM club option into a $19MM mutual option. That means he’ll be able to opt out in favor of a $1.5MM buyout and return to the open market in search of a multi-year deal.

Giolito is sure to go that route unless he suffers a major injury within the next few weeks. The 31-year-old righty is amidst his best season since he received down-ballot Cy Young votes each year between 2019-21. He has rebounded nicely from the elbow surgery that robbed him of his first year in Boston. Giolito returned this season on a $19MM player option. A Spring Training hamstring strain forced him to wait a few weeks to make his team debut, but he has been one of Boston’s most reliable starters behind Garrett Crochet over the past few months.

The righty’s first few starts were a little rocky. Giolito pitched to a 4.85 ERA across five appearances in May. He has performed well since then. Giolito has not allowed more than 3.41 earned runs per nine innings in any of the past four months. He carries a 2.86 ERA while averaging almost six innings per start in 18 appearances since the beginning of June. That doesn’t include tonight’s start, in which walks and a handful of inherited runners coming across the board left him with four earned runs through 4 2/3 innings.

All told, Giolito took a 3.30 ERA into today’s appearance. His 20% strikeout rate and 10% swinging strike mark are both a little below average. Giolito isn’t missing bats at the plus rates that he did during his early run with the White Sox, but he’s throwing strikes and working relatively deep into games. He has picked up 14 quality starts while tamping down on the home run issues that plagued him late in his time with Chicago (and during his brief stops with the Angels and Guardians in 2023).

Giolito is going into his age-31 season. He’s coming off a platform year that is arguably better than the one Luis Severino turned in for the Mets a year ago. Severino landed three years and $67MM with an opt-out after the second season. One could write that off as an anomaly by an A’s team that wanted to avoid a revenue sharing grievance and needed to overpay in the midst of a relocation. Even so, Giolito’s numbers stack up to those of Eduardo Rodriguez (four years, $80MM at age 31) and Michael Wacha (three years, $51MM at age 33) in their respective walk years.

Time will tell what kind of deal the market will bear for Giolito. His camp will probably take aim at four years. Even if that doesn’t materialize because of concerns about the dip in strikeouts or the home run issues he batted in previous seasons, he’ll easily beat the $17.5MM net call he faces in declining his end of the mutual option. That’s close to what rebound candidates like Walker Buehler, Alex Cobb and late-career Max Scherzer and Justin Verlander received last winter.

Boston can and almost certainly will tag Giolito with a qualifying offer, which would be in the $22MM range. In the likely event that Giolito declines, that’d entitle them to draft compensation. RosterResource estimates the Red Sox are narrowly above the $241MM luxury tax threshold. Assuming that’s the case, they’d receive a pick after the fourth round in 2026 if Giolito declines the QO and signs with another team.

Image courtesy of James A. Pittman, Imagn Images.

Yordan Alvarez To Miss Time With “Pretty Significant” Ankle Sprain

By | at

September 16: Espada said today that Alvarez has a “pretty significant” injury (via Matt Kawahara of The Houston Chronicle). The manager added that Alvarez would be “out for a while” but would not say whether he’ll be placed on the injured list or provide any further specifics on the timeline.

September 15: The Astros are sending Yordan Alvarez for an MRI on his left ankle, manager Joe Espada said postgame (via Space City’s Julia Morales). Houston’s star slugger gingerly exited tonight’s win over Texas in the first inning after hurting his ankle scoring a run. The club announced a few innings later that he was diagnosed with an ankle sprain. Chandler Rome of The Athletic observed that Alvarez was on crutches and in a walking boot in the clubhouse after the game.

Alvarez missed the bulk of the season with a small fracture in his right hand. He was out between the start of May and the final week of August. The three-time All-Star had started the year slowly but has raked since his return from the injured list. He’s hitting .369 with a trio of home runs in 18 games over the past three weeks. Alvarez has been in vintage form and is back as one of the team’s lineup anchors as they vie for a playoff spot.

The Astros have used Alvarez more frequently than they wanted in left field. That gave Jose Altuve more at-bats at designated hitter, though he’s been back at second base for the past few games. Victor Caratini stepped in at DH tonight. Alvarez’s exit pushed Jesús Sánchez from right to left field. Rookie Zach Cole came off the bench to play right field. Cole picked up a pair of hits and his second MLB home run in his first four games.

Cole would probably see an uptick in playing time in the corner outfield if Alvarez requires another injured list stint. Altuve could also see mostly everyday DH work with Mauricio Dubón stepping in as a defensive upgrade at second base.

Giants To Promote Bryce Eldridge

By | at

The Giants are calling up top prospect Bryce Eldridge, reports Susan Slusser of the San Francisco Chronicle. The club will need to make corresponding moves to get him onto the active and 40-man rosters.

Just over two weeks ago, it was reported that the Giants were unlikely to call up Eldridge this year, but a few things have changed since then. In late August, it seemed like the Giants were playing out the string on a lost season. They had sold at the deadline and were about seven games back of a playoff spot as August was winding down.

Eldridge was putting up good-not-great numbers in Triple-A. They could have called him up for a few big league at-bats, but he hasn’t even turned 21 years old yet and wasn’t really forcing the issue. If they had added him, they would have had to keep him on the roster through the winter. Keeping him in Triple-A would have afforded the club an extra roster spot through the offseason, since he wasn’t going to be Rule 5 eligible until December 2027.

But as mentioned, the picture has shifted. The Giants have played better of late as the Mets have fallen apart. That leaves San Francisco just 1.5 games back of a playoff spot now, with two weeks left in the regular season. A couple of days ago, they lost first baseman Dominic Smith to a hamstring strain, which pushed him onto the injured list.

Eldridge has also been in pretty good form lately. Since the reporting that he was likely not going to be called up, he has taken 78 more plate appearances at the Triple-A level. He hit four home runs in that span and drew walks at a 10.3% clip. His 28.2% strikeout rate in that stretch is still high but his .294/.372/.559 line translates to a 132 wRC+, even in the hitter-friendly environment of the Pacific Coast League.

Put it all together and it’s easy to see the appeal for the Giants. They have somehow found themselves with a real shot at cracking the postseason. Eldridge has long been one of their top prospects for a while and could help them make a push. The injury to Smith opened a path for him. Promoting Eldridge now will mean the club has one less roster spot to use in the winter, but that’s a small price to pay for the potential short-term benefits.

In the weeks prior to Smith’s injury, the Giants had a three-man rotation for the first base and designated hitter spots. Rafael Devers was playing everyday, alternating between DH and first base. It’s been less than two months that he’s been a first baseman, so it seems the Giants have been gradually getting him accustomed to that spot. Smith and Wilmer Flores were essentially platooning in the other slot, with the lefty-hitting Smith in there against righties and the righty-swinging Flores against lefties. One of them would be at first or DH, depending on where Devers was.

Eldridge hits from the left side and could perhaps take up the role that Smith was in previously. Eldridge doesn’t have huge splits here in 2025, with a .258/.333/.515 line against righties and .270/.330/.494 against lefties, but there was a stark difference in 2024. Last year, he had a .319/.406/.584 line with the platoon advantage but a .211/.272/.316 line otherwise. The improvements this year are very encouraging but the Giants might still shield him from lefties as they play competitive games for the next two weeks.

On the other hand, Flores had oddly reverse splits this year. He has a .223/.277/.362 line and 79 wRC+ against southpaws but a .248/.322/.383 line and 102 wRC+ otherwise. His career splits are more tilted towards the norm, as he has been slightly better against lefties, but he hasn’t been crushing them lately.

One way or another, Eldridge should be in there somewhere. It would be odd for the Giants to call him up just for a bench role, so they presumably plan on him getting somewhat regular playing time. He does have some right field experience in the minors but not since 2023. He has been exclusively a first baseman since the start of 2024. In the long run, he and Devers will presumably be sharing first base and the DH spot in some form. Devers is signed through 2033 while Eldridge will still have six seasons of club control beyond this one.

Since he only plays first base, Eldridge has a slightly lesser ceiling than a player who can cover a premium defensive spot, but he’s so good at the plate that he’s still a consensus top 30 prospect in the league. There’s not enough time remaining in the 2025 season for him to exhaust rookie eligibility, so he will still populate those prospect lists going into 2026, even if he is eventually part of a deep postseason run this year. By maintaining rookie status going into 2026, he will be eligible for the prospect promotion incentive. That means he could earn the Giants an extra draft pick if he cracks next year’s Opening Day roster and then meets certain awards voting criteria.

Photos courtesy of Sergio Estrada, Imagn Images

Mets Moving Sean Manaea To The Bullpen

By | at

The Mets are moving left-hander Sean Manaea to the bullpen, according to a report from Will Sammon and Tim Britton of The Athletic. Manaea told reporters before today’s game against the Rangers that he’s set to be available out of the bullpen during the game, and that if he’s not used in tonight’s game he’s likely to be used in relief of starter Clay Holmes for Tuesday’s series opener against the Padres.

The Mets, as noted by Sammon and Britton, have used a six-man rotation recently thanks to the promotions of rookies Jonah Tong, Brandon Sproat, Nolan McLean. With days off both tomorrow and next Monday, however, the Mets are opting to go back down to five starters through the end of the regular season. McLean (1.42 ERA in five starts) and Sproat (2.25 ERA in two starts) have both been nothing short of excellent, making it an easy decision to leave them both in the rotation alongside Holmes and Peterson. That left one spot in the rotation for Manaea and Tong, and New York will stick with the 22-year-old despite his six-run blow-up outing against the Rangers on Friday.

It’s hard to view that as anything other than a reflection of Manaea’s poor performance this year. The lefty was crucial to New York’s success in both the regular season and postseason last year, but was sidelined until just before the All-Star break by an oblique strain and a loose body in his elbow. His return to the mound hasn’t exactly inspired confidence, as he’s pitched to a 5.76 ERA in 50 innings of work across ten starts. While his 29.2% strikeout rate is incredibly impressive, particularly against a 4.6% walk rate, that’s led only to great peripherals like his 3.03 SIERA.

Manaea’s actual results have been well below par, and while much of that can be attributed to poor luck when it comes to sequencing and batted balls another real issue for the lefty has been keeping the ball in the park. He’s surrendered a career-high 9.4% barrel rate this year, and that’s led to ten home runs allowed this season. Perhaps move into a relief role can help him get things back on track over the final weeks of the regular season. If the Mets manage to make it to October despite their recent eight-game skid, Manaea will surely be crucial to keeping the pitching staff afloat regardless of what role he ends up pitching in.

Perhaps, if pitching in shorter bursts can help Manaea avoid the long ball over the next few weeks, he’ll be able to help stabilize a bullpen that has struggled badly of late. Ryan Helsley has never looked quite right since leaving the Cardinals, Reed Garrett and Ryne Stanek have faltered, and even Edwin Diaz blew a save and found himself on the hook for the loss in last night’s game against Texas. Typical pitching roles often go out the window in the postseason, and if Manaea is able to get big outs for the Mets in October out of the bullpen, they’d likely be happy to take that production even if it means him not being part of the rotation mix.

Another potential x-factor for the Mets is right-hander Kodai Senga, who has pitched like a front-of-the-rotation starter in the past but was optioned to Triple-A earlier this month after a string of eight starts where he pitched to a 6.56 ERA. Those starts came after a stint on the injured list due to a hamstring strain, however, and Senga looked incredible in six innings of work for Syracuse on Friday night. Perhaps he could bump Tong from the big league rotation before the end of the year if he continues to look good, and even if not Senga figures to be part of the Mets’ postseason pitching plans in some capacity if they make it there.

Blue Jays To Promote Trey Yesavage For MLB Debut

By | at

September 14: Yesavage will start Monday’s game against the Rays, manager John Schneider told reporters (including Nicholson-Smith) today. Schneider went on to make clear that Yesavage’s role beyond Monday’s game has not yet been decided. Arden Zwelling of Sportsnet adds that Schneider told reporters that Yesavage is not on an innings limit this year.

September 13: The Blue Jays are promoting right-hander Trey Yesavage to the majors, according to a report from Shi Davidi and Ben Nicholson-Smith of Sportsnet. Yesavage is expected to be active on the MLB roster for Monday’s game against the Rays in Tampa.

Yesavage, 22, was selected 20th overall in last year’s draft by Toronto. Viewed by most draft prospect evaluation services as a top-15 talent in his class at the time, he earned some top-100 prospect consideration this past offseason despite not having made his MLB debut yet thanks to a dominant 40.4% strikeout rate a 2.03 ERA in 15 starts for East Carolina last year. Yesavage began his season at the Single-A level and was promoted three separate times throughout the year. He made just four starts for High-A Vancouver before he was promoted to Double-A, and despite a 4.50 ERA in 30 innings at that level 38.0% strikeout rate was enough to convince Blue Jays brass to promote him to Triple-A last month.

Since then, he’s pitched to a 3.63 ERA in 17 1/3 innings of work while striking out 36.1% of his opponents. That’s an impressive enough figure that the Blue Jays decided to scratch Yesavage from his scheduled start with Buffalo tomorrow and call him up to the majors, though it shouldn’t be taken to mean Yesavage is completely without flaws. The youngster has walked 10.5% of his opponents this year, including 15.3% of his opponents at Triple-A. Those struggles with his command have generally been made up for by his impressive stuff, headlined by a fastball that sits 94-95 to go along with a splitter and a slider.

While the Blue Jays are still hard at work fending off the Yankees (who sit just three games back of Toronto in the AL East), they’re more or less assured of a spot in the postseason at this point. The club has a veteran rotation featuring Kevin Gausman, Max Scherzer, Shane Bieber, Chris Bassitt, and Jose Berrios as things stand. Yesavage is very unlikely to bump anyone from that group from the postseason rotation. It’s at least plausible the Jays could use Yesavage in spot starts over the season’s final weeks to help them line up their ideal postseason rotation for a potential Wild Card series, but the Jays have a real shot at a bye through the Wild Card round and would most likely benefit from seeing what Yesavage can do out of the bullpen.

Toronto’s bullpen has been flagging in recent weeks. Closer Jeff Hoffman has an ERA near 5.00, and deadline acquisition Louis Varland hasn’t taken to Canada very well despite his success in Minnesota earlier this year. With the late innings looking like a major question mark for the Jays headed into the postseason, trying Yesavage out of the bullpen and seeing if he can use his impressive stuff to dominate major league hitters in short bursts could result in the Jays having another power arm for their relief corps to lean on in October if the experiment goes well.

All that talk of October may sound confusing, given that the league’s rules state that a player may not be on a club’s postseason roster if not on the 40-man roster come September 1. There are ways around that, however, and one such loophole that would allow Yesavage to make a postseason roster this year is that clubs are allowed to replace players who are eligible to be activated off the injured list but not yet healthy enough to return, so long as the replacement was active in the organization prior to September 1. Yesavage meets those conditions, and the Jays have plenty of players who he could be considered a replacement for, such as Yimi Garcia.

Yesavage’s September call-up means that he’ll get at least a bit of major league service time this year, but we’ve long past the time where he would be in danger of losing rookie eligibility for the 2026 campaign. Toronto will need to create space on their 40-man roster in order to officially call Yesavage up to the majors on Monday by designating someone for assignment.

Dodgers Place Will Smith On Injured List

By | at

The Dodgers announced this evening that they’ve placed catcher Will Smith on the 10-day injured list, retroactive to September 10, due to a right hand contusion. Catcher Chuckie Robinson was recalled to replace Smith on the active roster.

Smith, 30, has enjoyed a career year with the Dodgers this season as he’s hit .296/404/.497 and landed his third consecutive All-Star appearance. Unfortunately, he was struck by a foul ball on his throwing hand on September 3. He sat out for nearly a week before he returned on September 9, but he hasn’t appeared in a game since. Manager Dave Roberts had previously described the issue as a matter of pain tolerance for Smith, as his ailing hand won’t heal before the end of the year at this point.

That seemed to suggest that Smith and the Dodgers were ready to have him play through the injury while talking days off when possible, but Roberts today told reporters (including Sonja Chen of MLB.com) that “not enough improvement”  has occurred in Smith’s ability to play at this point to continue giving him a spot on the roster and playing without a true backup catcher. Dalton Rushing is already on the injured list due to a shin contusion, which meant that third-string catcher Ben Rortvedt was the only option on the roster who was available in recent days.

Now that Smith has been placed on the shelf, there was room to get Rortvedt some help in the form of Robinson. Robinson has just 51 games in the big leagues to his name, and in that time has hit just .132/.170/.194 with a career wRC+ of -3, meaning he’s 103% worse than a league average hitter. It’s hardly a robust offensive profile, but he’s a very well-regarded defender and his right-handed bat could pair with Rortvedt’s lefty bat to form something of a platoon behind the plate, though neither player is offering much with the bat from either side of the plate.

Solid as Robinson and Rortvedt are defensively, it goes without saying that another week without Smith is a major blow to the Dodgers. He’s arguably been second only to Shohei Ohtani as the team’s most important player this year, and without him impacting the club on both sides of the ball everyday it’s been difficult for the Dodgers to lock up the NL West this September even while the Padres have gone 6-12 over their last 18 games. Surely, L.A.’s lead would be much larger than 2.5 games at this point if they had Smith in the middle of the lineup alongside Ohtani and Freddie Freeman.

That makes losing Smith for at least another week a tough pill to swallow, but at this point the Dodgers seem to view it as a necessary sacrifice in order to get Smith as healthy as possible in time for the start of the postseason. The Dodgers have just a 6.8% chance of clinching a bye through the Wild Card series according to Fangraphs, which means that Smith won’t get a substantial break between the regular season and the postseason to rest. The remaining regular season games are far less important than that three-game Wild Card set coming up in October, so it’s understandable that the Dodgers would be prioritizing getting Smith ready for that series at all costs at this point.

Given the nagging, day-to-day nature of Smith’s injury, it wouldn’t be a shock to see him activated after a minimum stay on the injured list. With that being said, it’s possible the Dodgers will want to give him as much time to heal up as possible over the final two weeks of the regular season, so perhaps they’ll take a more careful route with him and wait to bring him back until it’s time for him to tune up ahead of the postseason.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top